Vertex Pharmaceuticals Number of Operating Segments remained flat by 0.0% to $0.25 in Q4 2025 compared to the prior quarter.
Changes in this number reflect shifts in corporate strategy, such as restructuring, acquisitions, or divestitures.
The total count of distinct business units through which the company manages its operations and evaluates performance. T...
Standard disclosure in the 'Segment Information' note of the annual report.
is_cvx_number_of_operating_segments| FY'25 | |
|---|---|
| Value | $1.00 |
We use cookies for analytics. See our Privacy and Cookie Policy.